• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ondansetron Inovamed 2 mg/ml
    / Inovamed


    Active Ingredient
    Ondansetron (HCl dihydrate) 2 mg/ml

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Ampoule

    5 X 4 mg / 2 ml

    not in the basket chart 8525 15405

    Ampoule

    5 X 8 mg / 4 ml

    not in the basket chart 8534 15404

    Dosage

    8 mg as slow I.V./I.M. injection immediately before tretment.
    See prescribing information for full details.


    Indications

    Management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy and for prevention and treatment of post operative nausea and vomiting in adults and children aged 2 years and over.


    Contra-Indications

    Hypersensitivity to the active substance or to any of the excipients, pregnancy, lactation.
    See prescribing information for full details.


    Special Precautions

    Hepatic impairment.
    See prescribing information for full details.


    Side Effects

    Constipation, headache, sensation of warmth or flushing, hiccups, increases in liver function tests, rare cases of bronchospasm, tachycardia/bradycardia, angina, hypokalemia, transient visual disturbances, dizziness.
    See prescribing information for full details.


    Drug interactions

    See prescribing information for full details.


    Manufacturer
    Aurobindo Pharma, India
    Licence holder
    CLOSE